| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8216953 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 8 Pages |
Abstract
Addition of abiraterone to LHRHa with radiation is safe and achieves effective prostatic androgen suppression. Preliminary analysis of the clinical data is also promising, with excellent PSA nadir and no relapse to date in this high-risk population.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Eunpi MD, Elahe A. MD, PhD, Kenneth J. MD, Jay J. MD, Mark A. MS, Brenda F. PhD, Brett T. BS, Alvin M. MD, Bruce L. MD, R. Bruce MD,